The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
we didn't hang on in the 8-8.5p range, but still a gain.
Anyway. lets see what happens tomorrow...some chunky buts in the high 7's and a very high 9p+, so you'd think somethings afoot and that those sahres won't be sold soon either.
GLA, If we have a 10p Party in Vancouver I can be there :) ...looking forward to the realisation of profit after teh 10+ yrs I've held strong!
Such a strange post.... just because you’ve not used this training doesn’t mean no one has? Typical ‘I know better and best’ comment with no basis. How about a comment like ‘Wow, I do iron man events and haven’t ever trained that long, why do you and how do you find it? Same approach should be used for any different opinions here unless they are factually right or wrong. Back to the science and company now, where we seem to have a much more aligned board here recently which has been great!
Purely a frustrated post... but the Sclp PR machine seems to back in the lock up or even reversing through the back door. Surprised that with 2 larger Backers on board that they haven’t pushed into a more PR focused outlook after the media coverage and so rise. Still nothing we know of being wrong with the science thought GLA, hoping for a happy summer here!
Hey Ahfam, The point wasn’t really the prices, more that could we have offers tabled now before it could potentially be 5,10,15 times the price. Anyway we will see how it all plays out in the next 3-6 months I’m sure!
Being optimistic and with the amount of data/reviews indicating that Sar do have something of value, if not yet 100% proven you'd be surely of expecting a Pharma to potentially table an offer for license or for TO before the complete results come in, hoping they can get for 10p PS rather than 30p PS for example? Or there are NDA's in place an loose terms agreed when and if 1801 gets the green light.
Anyway going to be an interesting ride for sure from here on in. Ups & downs still, but the possibility of the shooting star RNS is there for everyone to see now! GLA
Just reading through the website to re-confirm what SCLP actually have in the pipeline, but there's some detail lacking on the most recent date sand timelines... most likley as thing shave drifted due to COVID for all the cancer progress.
However, does anyone have a projected timeline for the next news on each product/candidate... just as a quick overview of what may be expected short and medium term. Had been hoping that the Biontech collab would have brought more development/news than it has thus far.
Anyway just something to discuss whilst we hold for Covid news I hope, cheers
Agree, somewhat of a pause in the expected news flow at the moment due to the simple fact that things take time to test/progress and data to be obtained. Still think we could have a full TO of the company in 2021, but it may not be the 20p+ that some are hoping for unless they really hit the bullseye with a Tyk2 deal. I'll be holding until a deal/licenses at least part values the IP in the company and then assess from there.
Well not really that funny, but never allowed it to run up again after lunch and a sea of buys.
Anyway, we will wait for some positive news again for the next leg up. Hoping we can get above 2p as a base again before anything pivotal happens.
Yes it certainly seems like a little nod in the direction of the BOD being confident that they can access this funding if required.... therefore reducing the need/pressure for other funding right now!
Hoping things got up a little soon and we see some positive sentiment and news flow GLA
This is the very logical route now and I don’t think Redmile and Vulpes will want SCLP to miss this opportunity to significantly increase its Mcap and industry standing by letting these developments drift away.
Will a partner be waiting in the wings for an announcement this week or next... or at SCLP looking to maximize any potential partnership and wait the extra few weeks for the first human trial date? If that’s good then I’d say mega money and a vaccine ready for use before end of this year with the right backing.
And again this is an ‘extra’ opportunity on top of the excellent cancer pipelines. GLA
Thanks AB,
In reality I’m assuming Vulpes and then Redmile especially have been doing nothing but pushing the data/IP to their connections since arriving.
Just my turn to be a little bit frustrated with the lack of positive PR!
with the decline back from 17-18p when we thought we had some good sentiment and news/or coming... BOD need to get their **** together a little bit here or risk the continued overlooking by partners!!
Or the optimist in me thinks there’s a deal being ironed out... as how could the IP here be that ignored?
GLA
Wouldn’t surprise me if we ended up around 5% this afternoon, buys still coming in all disguises IMO. At some point we must surely get a holding notification, unless there are multiple buyers behind the continued large buys.
It would be nice to hear of an actual offer of anything in Sars pipeline. I believe it will come, but cannot help get frustrated that things haven't moved a little quicker and more transparently since middle of last year really, especially with all the 'need' and other deals going on. GLA
Yes I was looking waaay back to the RG comments when I was then newly invested here. I guess it was a little lazy of me to just stick to the £3+ sp valuation. But, IMO if we get just one licencing deal here with a major we could see £1 being realistic and then there are many more strings to the bow to deal on thereafter. An outright TO would have to be £s instead of pence, but we will hopefully see some kind of monetization in 2021. Anyway GLA and a healthy and happy new year